Magnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm Labor
- 1 July 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 110 (1), 61-67
- https://doi.org/10.1097/01.aog.0000269048.06634.35
Abstract
To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor. A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence. One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87% compared with 72%, P=.01). There were no differences in delivery within 48 hours (7.6% magnesium sulfate compared with 8.0% nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57% compared with 57%, P=.97, and 11% compared with 8%, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8+/-17.7 compared with 4.2+/-8.2 days, P=.007). Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects.Keywords
This publication has 19 references indexed in Scilit:
- Magnesium Sulfate TocolysisObstetrics & Gynecology, 2006
- Magnesium Sulfate: The First-Line TocolyticObstetrics and Gynecology Clinics of North America, 2005
- Trends in Preterm Birth and Perinatal Mortality Among Singletons: United States, 1989 Through 2000Obstetrics & Gynecology, 2005
- Risk–benefit effects of tocolytic therapyExpert Opinion on Drug Safety, 2004
- Obstetrical Accidents Involving Intravenous Magnesium SulfateMCN: The American Journal of Maternal/Child Nursing, 2004
- Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labourPediatric Radiology, 2004
- Tocolytic treatment for the management of preterm labor: A review of the evidenceAmerican Journal of Obstetrics and Gynecology, 2003
- Tocolytic Magnesium Sulfate Toxicity and Unexpected Neonatal DeathJournal of Perinatology, 2001
- The Control of LaborNew England Journal of Medicine, 1999
- Randomized investigation of magnesium sulfate for prevention of preterm birthAmerican Journal of Obstetrics and Gynecology, 1990